檢索結果 - Valerie Quarmby
- Showing 1 - 4 results of 4
-
1
Allelic variation in HLA‐DRB1 is associated with development of antidrug antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro 由 Christian Hammer, Jane Ruppel, Lynn Kamen, Julie Hunkapiller, Ira Mellman, Valerie Quarmby
出版 2022索引號: 載入...Connect to this object online.
位於: 載入...
圖書 -
2
Evaluation of atezolizumab immunogenicity: Efficacy and safety (Part 2) 由 Solange Peters, Peter R. Galle, Coen A. Bernaards, Marcus Ballinger, René Bruno, Valerie Quarmby, Jane Ruppel, Alexandr Vilimovskij, Benjamin Wu, Nitzan Sternheim, Martin Reck
出版 2022索引號: 載入...Connect to this object online.
位於: 載入...
圖書 -
3
Evaluation of atezolizumab immunogenicity: Clinical pharmacology (part 1) 由 Benjamin Wu, Nitzan Sternheim, Priya Agarwal, Julia Suchomel, Shweta Vadhavkar, Rene Bruno, Marcus Ballinger, Coen A. Bernaards, Phyllis Chan, Jane Ruppel, Jin Jin, Sandhya Girish, Amita Joshi, Valerie Quarmby
出版 2022索引號: 載入...Connect to this object online.
位於: 載入...
圖書 -
4
A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins 由 Andrzej M. Kierzek, Timothy P. Hickling, Isabel Figueroa, J. Cory Kalvass, Marjoleen Nijsen, Krithika Mohan, Geertruida M. Veldman, Akihiro Yamada, Hiroyuki Sayama, Sachiko Yokoo, Abhishek Gulati, Renu S. Dhanikula, Jochem Gokemeijer, Tarek A. Leil, Craig J. Thalhauser, Mario Giorgi, Maciej J. Swat, Vijayalakshmi Chelliah, Ben G. Small, Neil Benson, Michael Walker, Kapil Gadkar, Valerie Quarmby, Rong Deng, Andrea Ferrante, Gemma L. Dickinson, Jan‐Stefan Van Der Walt, Lian Zhou, Xiaoying Chen, Hannah M. Jones, Jatin Narula, Sophie Tourdot, Thierry Lavé, Benjamin Ribba, Piet H. van derGraaf
出版 2019索引號: 載入...Connect to this object online.
位於: 載入...
圖書